The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis
Abstract Background In spite of the multimodal treatment used today, glioblastoma is still the most aggressive and lethal cerebral tumour. To increase survival in these patients, novel therapeutic targets must be discovered. Signal transducer and activator of transcription 3 (Stat3), a transcription...
Main Authors: | Sergiu Susman, Radu Pîrlog, Daniel Leucuța, Andrei Otto Mitre, Vlad Adrian Padurean, Carmen Melincovici, Ioana Moldovan, Doinița Crișan, Stefan Ioan Florian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-019-0903-4 |
Similar Items
-
Ferroptosis Involvement in Glioblastoma Treatment
by: Andrei-Otto Mitre, et al.
Published: (2022-02-01) -
STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
by: Jennifer E. Kim, et al.
Published: (2014-02-01) -
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
by: Alexander Ou, et al.
Published: (2021-01-01) -
SH2B3, Transcribed by STAT1, Promotes Glioblastoma Progression Through Transducing IL-6/gp130 Signaling to Activate STAT3 Signaling
by: Shan Cai, et al.
Published: (2021-04-01) -
Roles of STAT3 in the pathogenesis and treatment of glioblastoma
by: Weijia Fu, et al.
Published: (2023-02-01)